Padaraju Annapurna, Dwivedi Falguni, Kumar Gautam
Department of Natural Products, Chemical Sciences, National Institute of Pharmaceutical Education & Research-Hyderabad, Hyderabad, Balanagar, 500037, India.
Ther Deliv. 2023 Nov;14(11):721-740. doi: 10.4155/tde-2023-0076. Epub 2023 Nov 28.
According to estimates, up to 25% of the world's population has fungal skin diseases, making them the most prevalent infectious disease. Several chemical classes of antifungal drugs are available to treat fungal infections. However, the major challenges of conventional formulations of antifungal drugs include poor pharmacokinetic profiles like solubility, low permeability, side effects and decreased efficacy. Novel drug delivery is a promising approach for overcoming pharmacokinetic limitations and increasing the effectiveness of antibiotics. In this review, we have shed light on microemulsions, nanoemulsions, and emulgels as novel drug delivery approaches for the topical delivery of antifungal antibiotics. We believe these formulations have potential translational value and could be developed for treating fungal infections in humans.
据估计,全球多达25%的人口患有真菌性皮肤病,使其成为最普遍的传染病。有几类化学抗真菌药物可用于治疗真菌感染。然而,传统抗真菌药物制剂的主要挑战包括药代动力学特性不佳,如溶解度低、渗透性差、副作用和疗效降低。新型药物递送是克服药代动力学限制和提高抗生素有效性的一种有前景的方法。在本综述中,我们阐明了微乳、纳米乳和乳胶凝剂作为抗真菌抗生素局部递送的新型药物递送方法。我们相信这些制剂具有潜在的转化价值,可开发用于治疗人类真菌感染。